We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$515M
AUM Growth
+$15.8M
Cap. Flow
+$4.8M
Cap. Flow %
0.93%
Top 10 Hldgs %
19.88%
Holding
127
New
2
Increased
93
Reduced
5
Closed
27

Top Buys

Rank Stock Value
1
NOVT icon
Novanta
NOVT
+$5.87M
2
PAY
Verifone Systems Inc
PAY
+$3.26M
3
CAMP
CalAmp Corp.
CAMP
+$2.03M
4
REI icon
Ring Energy
REI
+$1.67M
5
ASC icon
Ardmore Shipping
ASC
+$1.15M

Sector Composition

Rank Sector Weight
1 Industrials 20.07%
2 Technology 15.76%
3 Financials 14.21%
4 Healthcare 13.96%
5 Consumer Discretionary 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSG
1
DELISTED
Amsurg Corp
AMSG
$11.6M 2.26%
150,228
-14,831
-9% -$1.15M
EFOR
2
Everforth Inc
EFOR
$960M
$11.4M 2.22%
309,594
+10,790
+4% +$397K
CRI icon
3
Carter's
CRI
$1.43B
$11.3M 2.19%
105,762
+3,731
+4% +$385K
QTS
4
DELISTED
QTS REALTY TRUST, INC.
QTS
$10.8M 2.1%
193,136
+5,626
+3% +$290K
HASI icon
5
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$10.2M 1.98%
471,545
+8,924
+2% +$179K
PRXL
6
DELISTED
Parexel International Corp
PRXL
$9.86M 1.91%
156,770
+5,298
+3% +$328K
EEFT icon
7
Euronet Worldwide
EEFT
$3.19B
$9.68M 1.88%
139,891
+4,972
+4% +$378K
DY icon
8
Dycom Industries
DY
$11.2B
$9.58M 1.86%
106,740
+3,368
+3% +$254K
EFII
9
DELISTED
Electronics for Imaging
EFII
$9M 1.75%
209,133
+7,083
+4% +$298K
CUBI icon
10
Customers Bancorp
CUBI
$2.66B
$8.9M 1.73%
354,173
+10,916
+3% +$278K
ALE
11
DELISTED
Allete
ALE
$8.87M 1.72%
137,158
+3,099
+2% +$179K
MMSI icon
12
Merit Medical Systems
MMSI
$4.82B
$8.43M 1.64%
424,961
+14,552
+4% +$280K
MD icon
13
Pediatrix Medical
MD
$2.2B
$8.28M 1.61%
114,379
+4,062
+4% +$279K
MATW icon
14
Matthews International
MATW
$887M
$8.22M 1.6%
147,802
+5,488
+4% +$289K
MODV
15
DELISTED
ModivCare
MODV
$8.12M 1.58%
180,958
+5,874
+3% +$286K
PLKI
16
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$8.03M 1.56%
146,911
+4,705
+3% +$256K
FLWS icon
17
1-800-Flowers.com
FLWS
$252M
$7.61M 1.48%
843,255
+24,080
+3% +$191K
MSCC
18
DELISTED
Microsemi Corp
MSCC
$7.54M 1.47%
230,854
+2,369
+1% +$81.1K
EDE
19
DELISTED
Empire District Electric
EDE
$7.46M 1.45%
219,679
+9,092
+4% +$305K
NBHC icon
20
National Bank Holdings
NBHC
$1.9B
$7.45M 1.45%
365,901
+13,338
+4% +$272K
PVTB
21
DELISTED
PrivateBancorp Inc
PVTB
$7.18M 1.39%
163,051
+5,996
+4% +$244K
DGI
22
DELISTED
DigitalGlobe Inc.
DGI
$7.16M 1.39%
334,517
+11,019
+3% +$222K
ROG icon
23
Rogers Corp
ROG
$2.09B
$7.07M 1.37%
115,785
+4,034
+4% +$248K
BDC icon
24
Belden
BDC
$3.97B
$6.96M 1.35%
115,225
+3,621
+3% +$226K
AZPN
25
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$6.9M 1.34%
171,476
+5,402
+3% +$217K

Similar funds

Aristotle Capital Boston's Q2 2016 Portfolio in Review

As of Q2 2016, Aristotle Capital Boston held 127 positions worth $515M, up 3.2% from $499M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston's Q2 2016 filing shows 2 new, 93 increased, 5 reduced and 27 closed positions. Its largest new stake was Novanta: 381,748 shares worth $5.78M. The largest sale was JARDEN CORPORATION, an estimated $8.17M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Aristotle Capital Boston's largest Q2 2016 buy was Novanta: 381,748 shares worth $5.78M.
  • Aristotle Capital Boston added most to CalAmp Corp. in Q2 2016, an estimated $2.03M increase.
  • Aristotle Capital Boston's biggest Q2 2016 reduction was Amsurg Corp, cutting an estimated $1.15M.
  • Aristotle Capital Boston fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $8.17M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $515M portfolio in Q2 2016.
  • Aristotle Capital Boston opened 2 new positions and closed 27 in Q2 2016.
  • Aristotle Capital Boston's portfolio value rose 3.2% quarter-over-quarter to $515M.

Based on Aristotle Capital Boston's 13F filing for Q2 2016, filed 15 Aug 2016.